Bridging Science to Health, LLC

A Full Service Bio-Pharmaceutical Consulting Enterprise

Cassandra MacArthur
(720) 530-4457
Tim Burke
(216) 201-0294
Bridging Science to Health Regulatory
Quality
CMC-Manufacturing
Pre-Clinical
Clinical
Special Services

The Bridge from Research to Development and Beyond

Welcome to Bridging Science to Health, LLC. (BSH), formerly CMAC, LLC. and Bridging Health-Matters, LLC. (BrHM, LLC.). Bridging Science to Health, LLC. is a full-service Bio-Pharmaceutical and Medical Device consulting group. We pride ourselves on thinking outside of the box, with the ultimate goals of saving you time and money on your road to National and International Health Authority Approvals. Whether you are an academic scientist/medical doctor with your first product ready to progress out of the laboratory or a major bio-pharmaceutical/medical device company looking for assistance during a peak performance period, BSH has the expertise to assist you in bridging the gap.

Founded in 1992, BSH has established a stellar reputation for being innovative, efficient, responsive and successful in designing and implementing development programs (Manufacturing, Quality, Pre-clinical and Clinical), responding to delicate health authority queries, and negotiating collaborative health authority’s agreements. BSH has successfully developed and managed international programs including China and the EMEA and other emerging markets including Latin America, Australia, Korea, Russia, Mexico and South East Asia.

For an introduction to our principal strategists including current CVs, please visit the Principle Consultants page. Our consultant’s success stories can be found on the Achievements page. Read more about our comprehensive services in the Services section.

Prior clients include companies such as ARCA Biopharma, AVEVA Drug Delivery Systems, Cell>Point, LLC, Cleveland BioLabs Inc., Colorado Prevention Center, Helicon Therapeutics, Inc., ISIS Pharmaceuticals, Neurokey A/S in Denmark, Sanofi-Aventis, Upsher-Smith Laboratories, and ISO-Tex Diagnostics, Inc, Greffex, LLC., Eli Lilly and Company, Takeda Pharmaceuticals, Novartis, Pfizer, Medivation, Johnson & Johnson, among many others.

BSH would appreciate the opportunity to speak with you about the specific needs of your organization. With over 30 years of development expertise and a wide range of exceptional relationships both with the EMEA countries as well as the FDA, we are confident that we can assist your organization through development and beyond.